Bioinformatics is a branch of information technology concerned with the development of software for the analysis of biological data. Bioinformatics research covers a wide range of applications, including genome annotation, modelling, molecular folding, expression profiling, and gene/protein prediction.Bioinformatics' development and achievements are linked to computerised programming that is specifically intended to handle enormous amounts of DNA, RNA, proteins, and metabolites.
The growing need for nucleic acid and protein sequencing, rising initiatives from corporate and government organisations, accelerated expansion of proteomics and genomics, and rising research on molecular biology and drug discovery are all key factors for the bioinformatics industry. The worldwide bioinformatics platforms market is anticipated to develop rapidly during the forecast period as a result of the aforementioned factors.
MARKET SEGMENTATION:
• The worldwide Bioinformatics platforms market is divided into sequence analysis platforms, sequence alignment platforms, structural and functional analysis platforms, and others based on platform type.
• The market is divided into drug development, molecular genomics, gene therapy, customised medications, and others based on application.
• The market is divided into academic and research institutes, contract research organisations, and biotechnology firms based on end use.
The need for integrated bioinformatics systems in proteomics and genomics is also driving the bioinformatics industry forward. However, the bioinformatics market's growth is being stifled by a shortage of competent and educated professionals as well as excessive costs. Furthermore, the bioinformatics market's expansion is hampered by a lack of compatibility across data types. The newest trend in the bioinformatics industry is an increase in mergers and acquisitions, as well as new product creation. One of the bioinformatics market's growth potential is nanopore sequencing technology.
The major Key players operating in the global bioinformatics platforms market include, Affymetrix, Inc., Dassault Systemes, Agilent Technologies, QIAGEN, ID Business Solutions, Ltd., Agilent Technologies Inc., GenoLogics Life Sciences Software, Inc., and Illumina, Inc.